Asia-Pacific Offers Significant Growth Opportunities for Players in the Insulin Delivery Devices Market

The report "Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021" The insulin delivery devices market is expected to reach USD 17.8 billion by 2021 from USD 11.5 billion in 2016, at a CAGR of 9.1% during the forecast period.

The growth of the market is attributed favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population. Increasing research and development activities and increase in diabetes-related health expenditure in emerging economies are expected to offer significant growth opportunities for manufacturers in the coming years.          

Browse 100 market data tables and 38 figures spread through 149 pages and in-depth TOC on "Insulin Delivery Devices Market ".

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107632092

 Pens segment to dominate the market in 2016
Based on type, the insulin delivery devices market is categorized into pens, pumps, pen needles, syringes, and others (insulin inhalers, transdermal patches, and insulin jet injectors, among others). In 2016, the pens segment is expected to command the largest share of the insulin delivery devices market. The pens segment is further divided into reusable and disposable pens. The reusable pens segment is estimated to command the largest share of the insulin pens market in 2016. This large share can be attributed to lower price compared to disposable pens; availability of reimbursement in selected countries, and increasing adoption of insulin pens in the Asia-Pacific region.

Patients/Homecare segment is expected to grow at the highest CAGR  
By end user, the insulin delivery devices market is segmented into patients/homecare and hospitals & clinics.  The patients/homecare segment is estimated to command the largest share of the market in 2016 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be primarily attributed to the increasing diabetic population and rising healthcare expenditure.

North America to dominate the market
In 2016, North America is expected to account for the largest share of the global insulin delivery devices market. North America’s leadership position in the market can be attributed to the rising prevalence of diabetes and favorable reimbursement scenarios in the US and Canada, awareness activities, venture capital investments and issuance of IPOs in the US, and regulations for the usage of safety-engineered needles in Canada.During the forecast period, Asia-Pacific region is expected to register the highest growth rate. The high growth in the region can be attributed to the high adoption of insulin pens and approvals for injectable insulin in Japan, and the rising partnerships among the global and local players in Asia-Pacific countries are expected to support the growth of the Asia-Pacific insulin delivery devices market.

Read more:- https://www.marketsandmarkets.com/PressReleases/insulin-delivery-device.asp

The insulin delivery devices market is highly competitive with the presence of several small and big players. Some of the players in the insulin delivery devices market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (US), Tandem Diabetes Care, Inc. (US), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (US), and Insulet Corporation (US).

Ventilators Market worth $1.72 billion by 2027

The report "Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2027", is projected to reach USD 1.72 billion by 2027 from USD 0.93 billion in 2019, at a CAGR of 8.0%. Rising prevalence of respiratory diseases, increasing incidence of preterm births, urbanization and growing pollution levels, high prevalence of tobacco smoking, rapid growth in the geriatric population, and rising number of ICU beds are the major factors driving the growth of the ventilators market.

Browse 185 market data Tables and 56 Figures spread through 212 Pages and in-depth TOC on "Ventilator Market ".


“By mobility, the intensive care ventilators segment accounted for the largest share of the ventilators market in 2018.”

On the basis of mobility, the intensive case ventilators segment accounted for the largest share of the global ventilators market. The large share of this segment is attributed to the rising number of ICU beds and rising adoption of equipping the ICU beds with ventilators.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337 

“By interface, the invasive ventilation segment accounted for the largest share of the ventilators market in 2018.”

On the basis of interface, the invasive ventilation segment accounted for the largest share of the ventilators market. The large share of this segment is due to the high prevalence of tobacco smoking, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in the geriatric population, and improving healthcare affordability in developed countries.

“By end user, the hospitals and clinics segment of end user accounted for the largest share of ventilators market in 2018.”

Based on end user, the hospitals & clinics segment accounted for the largest share of the ventilators market. The large share of this segment can be attributed to the increasing number of private and public hospitals, economic expansion and focus of government on broader healthcare policies, and increasing per capita income.

“By type, the adult/pediatric ventilators segment held the largest market share of ventilators market in 2018.”

Based on type, the adult/pediatric ventilators segment held the largest market share of ventilators market. The large share of this segment can be attributed to the large patient population with severe COPD, asthma, and other chronic respiratory diseases; rising number of smokers; and rapid growth in the geriatric population.

Read more: - https://www.marketsandmarkets.com/PressReleases/ventilators.asp

“North America dominated the market in 2018.”

North America accounted for the largest share of the ventilators market in 2018, followed by Europe and Asia Pacific. The presence of major market players, the rising geriatric population, high prevalence of smoking, high prevalence of respiratory diseases, highly developed healthcare system, and high healthcare expenditure are the other factors responsible for the large share of North America in the ventilators market.

The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

Medical Image Analysis Software Market Size - Global Forecast to 2022

The report "Medical Image Analysis Software Market by Type (Standalone), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Dental, Oncology, Nephrology), End User (Hospital, Diagnostic Centre, Research) - Global Forecasts to 2022" The medical image analysis software market is expected to reach USD 3.88 billion by 2022 from USD 2.6 billion in 2017, at a CAGR of 8.2% during the forecast period. The growth of the market is attributed to technological advancements in medical imaging systems & analysis software, growing public- and private-sector investments in the medical imaging market, increasing use of imaging equipment due to rising prevalence of chronic diseases, fusion of imaging technologies, and growing applications of computer-aided diagnosis. Growing need for automated image analysis tools, rising adoption of cloud-based imaging solutions, and untapped emerging markets are expected to offer significant growth opportunities for manufacturers in the coming years.
                                         
Browse 303 Market Data Tables and 43 Figures spread through 313 Pages and in-depth TOC on "Medical Image Analysis Software Market “.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=846


Integrated software to dominate the market in 2017
Based on type, the medical image analysis software market is segmented into integrated and standalone software. In 2017, the integrated software segment is expected to account for the largest share of the medical image analysis software market. The compatibility of the software with the equipment is examined by the manufacturer beforehand and easy handling and fast processing are additional factors that contribute to the adoption of integrated image analysis software. However, the standalone software segment is expected to grow at the highest CAGR during the forecast period. Standalone software offers high flexibility and easy-to-use tools to inspect, evaluate, and process imaging data. These advantages are driving its growth in the market.

On the basis of end user, hospitals are projected to grow at the highest CAGR
By end user, the medical image analysis software market is segmented into hospitals, diagnostic centers, and research centers. Hospitals are expected to register the highest CAGR during the forecast period. The greater use of medical imaging software in hospitals & the higher installed base of diagnostic imaging systems (as compared to diagnostic and research centers) and high patient inflow (as compared to diagnostic centers) are expected to boost the demand for medical image analysis software in this segment.

North America to dominate the market followed by Europe
In 2017, North America is expected to account for the largest share of the market. The high growth of the North American market is attributed to the factors such as the growing geriatric population, high incidence/prevalence of various diseases, the large number of imaging centers in this region, ongoing research, fast adoption of technologically advanced imaging systems, and increasing awareness about the benefits of early disease diagnosis. In 2017, Europe is expected to hold the second largest share of this market. Factors such as rising incidence of chronic diseases and injuries, increasing demand for non-radiation diagnostic solutions, technological advancements and new product launches, large number of ongoing research activities, and increasing government and public-private investments are expected to fuel the market growth in this region.

Read More:- https://www.marketsandmarkets.com/PressReleases/medical-image-analysis.asp

The medical image analysis software market is highly competitive with the presence of several small and big players. Some of the players in the medical image analysis software market include AGFA Healthcare (Belgium), AQUILAB (France), Carestream Health, Inc. (US), Esaote S.p.A (Italy), GE Healthcare (US), Image Analysis (UK), INFINITT Healthcare Co, Ltd. (South Korea), Merge Healthcare, Inc. (US), MIM Software Inc. (US), Mirada Medical Limited (UK), Philips Healthcare (Netherlands), ScienceSoft USA Corporation (US), Siemens Healthineers (Germany), Toshiba Medical Systems Corporation (Japan), and Xinapse Systems Ltd (UK).

Mobile Health Solutions Market by Apps, Connected Devices & Services - 2022

The research report "mHealth Solutions Market by Connected Devices (Blood Pressure Monitor, Glucose Meter, Peak Flow Meter) Apps (Weight Loss, Woman Health, Personal Health Record, & Medication) Services (Diagnostic, Remote Monitoring, Consultation) - Global Forecasts to 2022", The global mHealth solutions market is expected to reach USD 90.49 Billion by 2022 from USD 21.17 Billion in 2017, at a CAGR of 33.7%.

Factors driving market growth include the increasing penetration of smartphones, tablets, and other mobile platforms, increasing utilization of connected devices and mHealth apps for the management of chronic diseases, and the rising cost containment in healthcare delivery. In addition, the penetration of 3G and 4G networks for uninterrupted healthcare services and rising focus on patient-centric healthcare delivery further increases the demand for mHealth solutions in the healthcare industry.

By product and service, the connected devices segment accounted for the largest share of the market in 2016
On the basis of product and service, the mHealth solutions market is segmented into connected medical devices, mHealth applications, and mHealth services. In 2016, connected medical devices accounted for the largest share of the mHealth solutions market, mainly due to the increasing incidence of chronic diseases and lifestyle-associated diseases requiring continuous health monitoring and the shifting consumer preferences towards a healthier lifestyle.

Browse and in-depth TOC on “mHealth Solutions Market”

313 - Tables

46 - Figures

375 - Pages 

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232

Within connected medical devices segment, the vital signs monitoring devices accounted for the largest share of the market
The connected medical devices market is further segmented into consumer health devices and clinical devices. Clinical devices segment is categorized into vital signs monitoring devices, peak flow meters, neurological monitoring devices, sleep apnea monitors, multi-parameter trackers, and others. In 2016, vital signs monitoring devices accounted for the largest share of of the global connected medical devices market. This is attributed to the rise in prevalence and incidence of diabetes and cardiovascular diseases across the globe and increasing adoption of continuous glucose monitoring (CGM) systems and various health monitoring devices.

Within mHealth applications segment, the healthcare applications accounted for the largest share of the market
The mHealth applications market is segmented into healthcare applications (designed for patients) by activity, and medical applications (designed for professionals). In 2016, the healthcare applications accounted for the largest share of the mHealth applications market. This growth is attributed to the factors such as increasing number of people using smart phones, the increasing preference for personal health and wellness app for self-health management and the increasing need for tracking daily activities and various health conditions of patients leading to the rising adoption of healthcare apps.

Within mHealth services segment, the remote monitoring services is expected to register the highest CAGR during the forecast period
On the basis of mHealth services, the market is categorized into remote monitoring, diagnosis services, treatment services, consultation services, fitness and wellness services, prevention services and healthcare system strengthening services. The remote monitoring services segment is expected to register the highest CAGR in the mHealth solutions market. The large share can be attributed to the increasing adoption of remote monitoring solutions by patients in remote rural areas and technological advancements in medicine and telecommunication.

Read more:-  https://www.marketsandmarkets.com/PressReleases/mhealth-apps-and-solutions.asp

North America dominated the market in 2016
In 2016, North America dominated the global mHealth solutions market. The increasing demand for better healthcare services, government initiatives for digital health, stringent regulations regarding patient safety and patient care, and increasing number of smartphone users coupled with the rising awareness of self-health management are driving the growth of the mHealth solutions market in this region.

The key players in the mHealth solutions market are Medtronic plc (Ireland), Apple, Inc. (U.S.), AirStrip Technologies, Inc. (U.S.), AliveCor, Inc. (U.S.), LifeWatch AG (Switzerland), Nike Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Jawbone (U.S.), OMRON Corporation (Japan), Withings (France), BioTelemetry Inc. (U.S.), athenahealth, Inc. (U.S.), AgaMatrix, Inc. (U.S.), iHealth Lab, Inc. (U.S.), AT&T (U.S.), Qualcomm (U.S.), Cerner Corporation (U.S.), and Cisco Systems, Inc. (U.S.), and Nokia Corporation (Finland).

Leading Players in the Nerve Repair and Regeneration Market

The research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022", The nerve repair and regeneration market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

By neurostimulation and neuromodulation device product, the internal neurostimulation device segment is expected to dominate the market in 2017

On the basis of neurostimulation and neuromodulation device product is subsegmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017. This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883

By end user, the hospitals and clinics segment is expected to dominate the market in 2017
In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market. The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

Browse and in-depth TOC on “Nerve Repair and Regeneration Market”

83 - Tables

31 - Figures

122 - Pages

Asia offers lucrative growth opportunities By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to register the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing neurological disorder in the region are some major factors driving the high growth of this regional segment.

Know more: - https://www.marketsandmarkets.com/PressReleases/nerve-repair-regeneration.asp

Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).